Experiments for taxon Polygonum cuspidatum (POLYGONACEAE)

398 experiments

Experiment	Worktypes	Pharmacology	Organism (specimen)	Compound
1216305	VOUCHER SPECIMEN REPORTED FORANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)MEDICINAL FOLKLORE REPORTED FOR	ANTIBACTERIAL ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
295790	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	CATECHIN,(+):
295781	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)	LYONIRESINOL-2(A)-SULFATE,SODIUM: (-):LARICIRESINOL-2(A)-SULFATE,ISO: SODIUM: (+):ETHANE-1-2-DIOL,1-(3-5-DIHYDROXY-PHENYL)-2-(4''-HYDROXY-PHENYL):BENZOIC ACID METHYL ESTER-4-SULFATE,3-4-DIHYDROXY-5-METHOXY: SODIUM:
1065401	PHARMACOLOGY OF EXTRACT - IN VIVO	GLUTAMATE-PYRUVATE STIMULATION	Polygonum cuspidatum (POLYGONACEAE)	TANNIN(CONDENSED)
969059	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIMUTAGENIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
711496	PHARMACOLOGY OF COMPOUND - IN VITRO	CELL ADHESION INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL,TRANS:
856798	PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS	ANTIHYPERLIPEMIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
716842	PHARMACOLOGY OF COMPOUND - IN VITRO	ESTROGEN RECEPTOR(BETA) BINDING EFFECT	Polygonum cuspidatum (POLYGONACEAE)	EMODIN-8-O-BETA-D-GLUCOSIDE
295784	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FOR		Polygonum cuspidatum (POLYGONACEAE)	LARICIRESINOL-2(A)-SULFATE,ISO: SODIUM: (+):
1098982	ANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)MEDICINAL FOLKLORE REPORTED FOR	ANTIFUNGAL ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
295795	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	TACHIOSIDE
1089472	PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FORANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
1114840	MEDICINAL FOLKLORE REPORTED FOR	HYPOCHOLESTEROLEMIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
607491	PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS	TYROSINASE INHIBITION	Polygonum cuspidatum (POLYGONACEAE)
1278272	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATAHPLC SEPARATION DATA FOR		Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL,TRANS:
758695	PHARMACOLOGY OF COMPOUND - IN VITRO	RNA SYNTHESIS INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	RESVERATROLPICEID
412033	ANTIFERTILITYMEDICINAL FOLKLORE REPORTED FOR	UTERINE RELAXATION EFFECT	Polygonum cuspidatum (POLYGONACEAE)
1159116	PHARMACOLOGY OF EXTRACT - IN VIVO	BARBITURATE SLEEPING TIME DECREASED	Polygonum cuspidatum (POLYGONACEAE)
1070794	PHARMACOLOGY OF EXTRACT - IN VITROANTIFERTILITY	UTERINE STIMULANT EFFECT	Polygonum cuspidatum (POLYGONACEAE)
534704	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIOXIDANT ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
712273	PHARMACOLOGY OF EXTRACT - IN VITRO	RADICAL SCAVENGING EFFECT	Polygonum cuspidatum (POLYGONACEAE)
262123	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL,CIS: 3-O-BETA-D-GLUCOPYRANOSIDE-4''-SULFATERESVERATROL,TRANS: 3-O-BETA-D-GLUCOPYRANOSIDE-4''-SULFATERESVERATROL,CIS: 3-O-BETA-D-GLUCOPYRANOSIDE-5-SULFATERESVERATROL,CIS: 3-O-BETA-D-GLUCOPYRANOSIDE-6''-SULFATERESVERATROL,TRANS: 3-O-BETA-D-GLUCOPYRANOSIDE-2''-SULFATERESVERATROL,TRANS: 3-O-BETA-D-GLUCOPYRANOSIDE-5-SULFATERESVERATROL,CIS: 3-O-BETA-D-GLUCOPYRANOSIDE-2''-SULFATERESVERATROL,TRANS: 3-O-BETA-D-GLUCOPYRANOSIDE-4'-SULFATERESVERATROL,CIS: 3-O-BETA-D-GLUCOPYRANOSIDE-3''-SULFATERESVERATROL,TRANS: 3-O-BETA-D-GLUCOPYRANOSIDE-6''-SULFATE
1098993	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL
876110	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	EMODIN-8-O-BETA-D-GLUCOSIDE
561454	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIMUTAGENIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
584252	VOUCHER SPECIMEN REPORTED FOR		Polygonum cuspidatum (POLYGONACEAE)
1142815	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTIHEPATOTOXIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)	PICEID
1114845	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	PROTOCATECHUIC ACID
924759	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANS	HYPOLIPEMIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
1244741	ISOLATION AND IDENTIFICATION AFTER CHEMICAL TREATMENT		Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL
769605	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL,TRANS:
552746	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIMUTAGENIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
295778	VOUCHER SPECIMEN REPORTED FOR		Polygonum cuspidatum (POLYGONACEAE)
280449	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)	POLYGONUM DIMERIC STILBENE GLYCOSIDE 2
1300964	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIOXIDANT ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
295788	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	TRYPTOPHAN
1148009	PHARMACOLOGY OF COMPOUND - IN VITRO	CHOLESTEROL INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	PICEID
492684	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)	PICEID
31438	IDENTIFICATION IN BY PAPER CHROMATOGRAPHYCHEMOTAXONOMY MARKER CODE		Polygonum cuspidatum (POLYGONACEAE)	QUERCITRINAVICULARINHYPEROSIDERUTIN
1261284	MICROSCOPY OF		Polygonum cuspidatum (POLYGONACEAE)
579000	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIULCER ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
280438	PHARMACOLOGY OF COMPOUND - IN VITRO	MALONDIALDEHYDE INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	POLYGONUM DIMERIC STILBENE GLYCOSIDE 1
1098986	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL
1324915	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTIINFLAMMATORY ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)	POLYSACCHARIDE(POLYGONUM CUSPIDATUM)
876108	PHARMACOLOGY OF COMPOUND - IN VITRO	DNA SYNTHESIS INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	EMODIN
876107	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)	EMODIN
362558	PHARMACOLOGY OF EXTRACT - IN VITRO	TYROSINASE INHIBITION	Polygonum cuspidatum (POLYGONACEAE)
848018	PHARMACOLOGY OF COMPOUND - IN VITRO	CYCLOOXYGENASE INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	PICEID
1148003	PHARMACOLOGY OF COMPOUND - IN VIVO	LIPID METABOLISM EFFECTS	Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL
751364	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIOXIDANT ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)	DECURSINOL ANGELATE
1114839	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	FALLACINOL
1303471	PHARMACOLOGY OF COMPOUND - IN VITRO	TYROSINASE INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	RESVERATROLPICEID
779880	PHARMACOLOGY OF EXTRACT - IN VITRO	QUINONE REDUCTASE INDUCTION	Polygonum cuspidatum (POLYGONACEAE)
1114849	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	TORACHRYSONE-8-O-BETA-D-GLUCOSIDE
779879	PHARMACOLOGY OF EXTRACT - IN VITRO	QUINONE REDUCTASE INDUCTION	Polygonum cuspidatum (POLYGONACEAE)
704298	PHARMACOLOGY OF EXTRACT - IN VITRO	RADICAL SCAVENGING EFFECT	Polygonum cuspidatum (POLYGONACEAE)
1098983	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL
1202431	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIVIRAL ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
771522	PHARMACOLOGY OF EXTRACT - IN VITRO	SUPEROXIDE RADICAL SCAVENGING ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
280445	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FOR		Polygonum cuspidatum (POLYGONACEAE)	POLYGONUM DIMERIC STILBENE GLYCOSIDE 2
1243456	ISOLATION AND IDENTIFICATION AFTER CHEMICAL TREATMENT		Polygonum cuspidatum (POLYGONACEAE)	POLYDATOGENOL
758696	PHARMACOLOGY OF COMPOUND - IN VITRO	METABOLISM INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	RESVERATROLPICEID
1142821	ISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL
692062	PHARMACOLOGY OF EXTRACT - IN VITRO	MELANIN FORMATION INHIBITION	Polygonum cuspidatum (POLYGONACEAE)
496133	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL-4'-O-BETA-D-GLUCOSIDE
876118	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	PHYSCION-8-O-BETA-D-GLUCOSIDE
876119	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)	PHYSCION-8-O-BETA-D-GLUCOSIDE
706398	ISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	PICEID,TRANS:
262135	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL,CIS: 3-O-BETA-D-GLUCOPYRANOSIDE-5-SULFATE
876120	PHARMACOLOGY OF COMPOUND - IN VITRO	DNA SYNTHESIS INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	PHYSCION-8-O-BETA-D-GLUCOSIDE
411992	ANTIFERTILITYMEDICINAL FOLKLORE REPORTED FOR	MENSTRUATION INDUCTION EFFECT	Polygonum cuspidatum (POLYGONACEAE)
711491	PHARMACOLOGY OF COMPOUND - IN VITRO	CELL CYCLE CYTOTOXICITY(G2 + M PHASE)	Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL,TRANS:
973958	ISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	EMODIN
711486	ISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL,TRANS:
711493	PHARMACOLOGY OF COMPOUND - IN VITRO	CALCIUM CHANNEL BLOCKER	Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL,TRANS:
280450	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)	POLYGONUM DIMERIC STILBENE GLYCOSIDE 2
1244957	CRUDE DRUG DESCRIPTION		Polygonum cuspidatum (POLYGONACEAE)
295789	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	BENZOIC ACID,2-6-DIHYDROXY:
1216301	VOUCHER SPECIMEN REPORTED FOR		Polygonum cuspidatum (POLYGONACEAE)
1070463	PHARMACOLOGY OF EXTRACT - IN VIVOVOUCHER SPECIMEN REPORTED FOR	BARBITURATE POTENTIATION	Polygonum cuspidatum (POLYGONACEAE)
1190700	MEDICINAL FOLKLORE REPORTED FOR	ESCHAROTIC EFFECT	Polygonum cuspidatum (POLYGONACEAE)
750376	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL
1114850	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Polygonum cuspidatum (POLYGONACEAE)	JUGLONE,6-ACETYL-2-METHOXY-7-METHYL:
969060	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIMUTAGENIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
1142816	PHARMACOLOGY OF COMPOUND - IN VITRO	LIPID PEROXIDE FORMATION INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	PICEID
295791	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	CATECHIN,(+): 5-O-BETA-D-GLUCOPYRANOSIDE
741052	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIBACTERIAL ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
1278273	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATAHPLC SEPARATION DATA FOR		Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL,TRANS: BETA-D-GLUCOSIDE
848014	PHARMACOLOGY OF COMPOUND - IN VITRO	PLATELET AGGREGATION INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL
497224	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIVIRAL ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
497223	PHARMACOLOGY OF EXTRACT - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIVIRAL ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
697978	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIMUTAGENIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
876111	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)	EMODIN-8-O-BETA-D-GLUCOSIDE
492677	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL
1244747	IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	QUERCITRIN,ISO:
1198625	MEDICINAL FOLKLORE REPORTED FOR	LIVER EFFECTS(UNSPECIFIED)	Polygonum cuspidatum (POLYGONACEAE)
924762	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANS	HYPOLIPEMIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
540250	PHARMACOLOGY OF EXTRACT - IN VITRO	PLATELET ACTIVATING FACTOR BINDING INHIBITION	Polygonum cuspidatum (POLYGONACEAE)
697977	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIMUTAGENIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
1300120	PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FOR	ANTIOXIDANT ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
716834	PHARMACOLOGY OF COMPOUND - IN VITROANTIFERTILITY	ESTROGENIC EFFECT	Polygonum cuspidatum (POLYGONACEAE)	ALOE EMODINCHRYSOPHANIC ACIDCHRYSAZIN
711497	PHARMACOLOGY OF COMPOUND - IN VITRO	CELL ADHESION INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL,TRANS:
561458	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIMUTAGENIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)	EMODIN
496131	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	PICEID
1089471	PHARMACOLOGY OF EXTRACT - IN VIVOVOUCHER SPECIMEN REPORTED FOR	TOXICITY ASSESSMENT(QUANTITATIVE)	Polygonum cuspidatum (POLYGONACEAE)
295782	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)	LYONIRESINOL-2(A)-SULFATE,SODIUM: (-):LARICIRESINOL-2(A)-SULFATE,ISO: SODIUM: (+):ETHANE-1-2-DIOL,1-(3-5-DIHYDROXY-PHENYL)-2-(4''-HYDROXY-PHENYL):BENZOIC ACID METHYL ESTER-4-SULFATE,3-4-DIHYDROXY-5-METHOXY: SODIUM:
534701	PHARMACOLOGY OF EXTRACT - IN VITRO	RADICAL SCAVENGING EFFECT	Polygonum cuspidatum (POLYGONACEAE)
1244951	IDENTIFICATION OFQUANTITATIVE DATA REPORTED		Polygonum cuspidatum (POLYGONACEAE)	EMODIN
854209	PHARMACOLOGY OF EXTRACT - IN VIVO	CAPILLARY PERMEABILITY DECREASED	Polygonum cuspidatum (POLYGONACEAE)
295793	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL
1070795	PHARMACOLOGY OF EXTRACT - IN VITROANTIFERTILITY	UTERINE RELAXATION EFFECT	Polygonum cuspidatum (POLYGONACEAE)
1300965	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIBACTERIAL ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
262124	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIFUNGAL ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL,CIS: 3-O-BETA-D-GLUCOPYRANOSIDE-4''-SULFATERESVERATROL,TRANS: 3-O-BETA-D-GLUCOPYRANOSIDE-4''-SULFATERESVERATROL,CIS: 3-O-BETA-D-GLUCOPYRANOSIDE-5-SULFATERESVERATROL,CIS: 3-O-BETA-D-GLUCOPYRANOSIDE-6''-SULFATERESVERATROL,TRANS: 3-O-BETA-D-GLUCOPYRANOSIDE-2''-SULFATERESVERATROL,TRANS: 3-O-BETA-D-GLUCOPYRANOSIDE-5-SULFATERESVERATROL,CIS: 3-O-BETA-D-GLUCOPYRANOSIDE-2''-SULFATERESVERATROL,TRANS: 3-O-BETA-D-GLUCOPYRANOSIDE-4'-SULFATERESVERATROL,CIS: 3-O-BETA-D-GLUCOPYRANOSIDE-3''-SULFATERESVERATROL,TRANS: 3-O-BETA-D-GLUCOPYRANOSIDE-6''-SULFATE
973957	VOUCHER SPECIMEN REPORTED FOR		Polygonum cuspidatum (POLYGONACEAE)
414123	CHEMOTAXONOMY MARKER CODEISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	QUERCETINKAEMPFEROL
280439	PHARMACOLOGY OF COMPOUND - IN VITRO	LIPID PEROXIDE FORMATION INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	POLYGONUM DIMERIC STILBENE GLYCOSIDE 1
578999	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIULCER ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
561453	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIMUTAGENIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
1142814	PHARMACOLOGY OF COMPOUND - IN VIVO	LIPID PEROXIDE FORMATION INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	PICEID
751363	ISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	DECURSINOL ANGELATE
848011	PHARMACOLOGY OF COMPOUND - IN VITRO	CYCLOOXYGENASE INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL
716835	ISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	EMODIN
779881	PHARMACOLOGY OF EXTRACT - IN VITRO	QUINONE REDUCTASE INDUCTION	Polygonum cuspidatum (POLYGONACEAE)
650484	PHARMACOLOGY OF EXTRACT - IN VITRO	CELL DIFFERENTIATION INDUCTION	Polygonum cuspidatum (POLYGONACEAE)
552747	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIMUTAGENIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)	EMODIN
876106	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	EMODIN
1098994	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL
711490	PHARMACOLOGY OF COMPOUND - IN VITRO	APOPTOSIS INDUCTION	Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL,TRANS:
856795	PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS	LIVER EFFECTS(UNSPECIFIED)	Polygonum cuspidatum (POLYGONACEAE)
530307	MEDICINAL FOLKLORE REPORTED FOR	ANTIVENIN EFFECT	Polygonum cuspidatum (POLYGONACEAE)
1148010	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTIHYPERCHOLESTEROLEMIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)	PICEID
716838	PHARMACOLOGY OF COMPOUND - IN VITRO	ESTROGEN RECEPTOR(BETA) BINDING EFFECT	Polygonum cuspidatum (POLYGONACEAE)	EMODIN
550645	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIMUTAGENIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
1293445	IDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED		Polygonum cuspidatum (POLYGONACEAE)	RESVERATROLPICEID
1070213	IDENTIFICATION IN BY PAPER CHROMATOGRAPHY		Polygonum cuspidatum (POLYGONACEAE)
1159115	PHARMACOLOGY OF EXTRACT - IN VIVO	BARBITURATE POTENTIATION	Polygonum cuspidatum (POLYGONACEAE)
876109	PHARMACOLOGY OF COMPOUND - IN VITRO	RNA SYNTHESIS INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	EMODIN
848020	PHARMACOLOGY OF COMPOUND - IN VITRO	PLATELET AGGREGATION INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	PICEID
1244103	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	EMODIN
937910	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIVIRAL ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
1244742	YIELD IS MORE THAN 100 MGMQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Polygonum cuspidatum (POLYGONACEAE)	PICEID
876117	PHARMACOLOGY OF COMPOUND - IN VITRO	RNA SYNTHESIS INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	PHYSCION
1142819	MEDICINAL FOLKLORE REPORTED FOR	ANTIINFLAMMATORY ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
741053	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIBACTERIAL ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
1098987	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL
492685	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)	PICEID
770970	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIVIRAL ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
1242659	ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Polygonum cuspidatum (POLYGONACEAE)	PHYSCION-8-O-BETA-D-GLUCOSIDEEMODIN-8-O-BETA-D-GLUCOSIDE
848019	PHARMACOLOGY OF COMPOUND - IN VITRO	CYCLOOXYGENASE INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	PICEID
1303470	PHARMACOLOGY OF COMPOUND - IN VITRO	TYROSINASE INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	EMODINPHYSCIONCITREOROSEIN
1098995	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL
295796	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	EMODIN-8-O-BETA-D-GLUCOPYRANOSIDE
716839	ISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	EMODIN-8-O-BETA-D-GLUCOSIDE
876121	PHARMACOLOGY OF COMPOUND - IN VITRO	RNA SYNTHESIS INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	PHYSCION-8-O-BETA-D-GLUCOSIDE
924761	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANS	HYPOTRIGLYCERIDEMIA ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
27706	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIINFLAMMATORY ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
1098991	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIFUNGAL ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL
1261286	QUANTITATIVE DATAISOLATION AND IDENTIFICATION AFTER CHEMICAL TREATMENT		Polygonum cuspidatum (POLYGONACEAE)	EMODIN
850363	PHYTOCHEMICAL SCREENING FOR		Polygonum cuspidatum (POLYGONACEAE)	OOOO
597744	PHARMACOLOGY OF EXTRACT - IN VITRO	REVERSE TRANSCRIPTASE INHIBITION	Polygonum cuspidatum (POLYGONACEAE)
711498	ISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	PICEID
1282586	PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FOR	ESTROGENIC EFFECT	Polygonum cuspidatum (POLYGONACEAE)
876103	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)	CHRYSOPHANIC ACID
496127	VOUCHER SPECIMEN REPORTED FOR		Polygonum cuspidatum (POLYGONACEAE)
848021	PHARMACOLOGY OF COMPOUND - IN VITRO	PLATELET AGGREGATION INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	PICEID
1244746	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	QUERCITRINREYNOUTRIN
779878	VOUCHER SPECIMEN REPORTED FOR		Polygonum cuspidatum (POLYGONACEAE)
706397	ISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL,TRANS:
1098984	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIFUNGAL ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL
280442	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)	POLYGONUM DIMERIC STILBENE GLYCOSIDE 1
1114846	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	CATECHIN,(+):
492681	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	PICEID
711487	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTITUMOR ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL,TRANS:
1139272	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMUTAGENIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
295792	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	ETHANONE,1-(3-O-BETA-D-GLUCOPYRANOSYL-4-5-DIHYDROXY-PHENYL):
1148007	ISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	PICEID
534705	PHARMACOLOGY OF EXTRACT - IN VITRO	CYTOPROTECTIVE ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
497225	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIVIRAL ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
1089475	PHARMACOLOGY OF EXTRACT - IN VIVOVOUCHER SPECIMEN REPORTED FORANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTITUMOR ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
262127	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL,TRANS: 3-O-BETA-D-GLUCOPYRANOSIDE-4''-SULFATE
496132	PHARMACOLOGY OF COMPOUND - IN VITRO	PROTEIN TYROSINE KINASE INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	PICEID
373214	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	QUERCITRINQUERCETINVICENIN 2QUERCETIN-3-O-ARABINOGLUCOSIDELUTEOLIN,6-8-DI-C-GLUCOSYL:
973961	PHARMACOLOGY OF COMPOUND - IN VITRO	TYROSINE KINASE INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	PHYSCION
876125	PHARMACOLOGY OF COMPOUND - IN VITRO	RNA SYNTHESIS INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	PICEID
1244800	ISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	EMODIN MONOMETHYL ETHERCHRYSOPHANIC ACIDEMODIN
1070791	PHARMACOLOGY OF EXTRACT - IN VITRO	SMOOTH MUSCLE STIMULANT ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
937911	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIVIRAL ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
280446	PHARMACOLOGY OF COMPOUND - IN VITRO	MALONDIALDEHYDE INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	POLYGONUM DIMERIC STILBENE GLYCOSIDE 2
295785	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Polygonum cuspidatum (POLYGONACEAE)	ETHANE-1-2-DIOL,1-(3-5-DIHYDROXY-PHENYL)-2-(4''-HYDROXY-PHENYL):
854208	PHARMACOLOGY OF EXTRACT - IN VIVO	VASODILATOR ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
601599	ISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	EMODIN
561457	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIMUTAGENIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)	EMODIN
502159	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	VERMIFUGE ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
1065402	PHARMACOLOGY OF EXTRACT - IN VIVO	HEPATOTOXIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)	TANNIN(CONDENSED)
1142818	ANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)MEDICINAL FOLKLORE REPORTED FOR	ANTIFUNGAL ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
552748	PHARMACOLOGY OF EXTRACT - IN VITRO	GENOTOXICITY INHIBITION	Polygonum cuspidatum (POLYGONACEAE)
586474	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
881086	IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	QUERCITRINQUERCETINGALLIC ACIDQUERCITRIN,ISO:
1216302	VOUCHER SPECIMEN REPORTED FORANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)MEDICINAL FOLKLORE REPORTED FOR	ANTIVIRAL ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
876114	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	PHYSCION
1142822	PHARMACOLOGY OF COMPOUND - IN VITRO	LIPID PEROXIDE FORMATION INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL
395893	IDENTIFICATION IN BY GLCQUANTITATIVE DATA REPORTED		Polygonum cuspidatum (POLYGONACEAE)	STEROL ANALYSIS
1142811	ISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	PICEID
635822	PHARMACOLOGY OF EXTRACT - IN VITRO	TYROSINASE INHIBITION	Polygonum cuspidatum (POLYGONACEAE)
1070796	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	Polygonum cuspidatum (POLYGONACEAE)
848013	PHARMACOLOGY OF COMPOUND - IN VITRO	PLATELET AGGREGATION INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL
876116	PHARMACOLOGY OF COMPOUND - IN VITRO	DNA SYNTHESIS INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	PHYSCION
706396	PHARMACOLOGY OF COMPOUND - IN VITRO	METABOLISM INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL,CIS:
876105	PHARMACOLOGY OF COMPOUND - IN VITRO	RNA SYNTHESIS INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	CHRYSOPHANIC ACID
1244102	MEDICINAL FOLKLORE REPORTED FOR	LAXATIVE EFFECT	Polygonum cuspidatum (POLYGONACEAE)
561456	ISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	EMODIN
700364	VOUCHER SPECIMEN REPORTED FOR		Polygonum cuspidatum (POLYGONACEAE)
937912	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
751362	PHARMACOLOGY OF COMPOUND - IN VITRO	NITRIC OXIDE SYNTHESIS INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	DECURSIN
534702	PHARMACOLOGY OF EXTRACT - IN VITRO	RADICAL SCAVENGING EFFECT	Polygonum cuspidatum (POLYGONACEAE)
1282587	PHARMACOLOGY OF EXTRACT - IN VITRO	ESTROGENIC EFFECT	Polygonum cuspidatum (POLYGONACEAE)
848010	PHARMACOLOGY OF COMPOUND - IN VITRO	LIPOXYGENASE INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL
262132	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL,CIS: 3-O-BETA-D-GLUCOPYRANOSIDE-4''-SULFATE
1138201	IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	CINNAMIC ACIDCITRIC ACIDMALIC ACIDOXALIC ACIDTARTARIC ACID
703281	PHARMACOLOGY OF EXTRACT - IN VITRO	PROTEASE(HIV) INHIBITION	Polygonum cuspidatum (POLYGONACEAE)
262129	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL,TRANS: 3-O-BETA-D-GLUCOPYRANOSIDE-4'-SULFATE
734726	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL
1139273	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMUTAGENIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
760441	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIVIRAL ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
1278270	IDENTIFICATION IN BY HPLC		Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL,CIS:
716836	PHARMACOLOGY OF COMPOUND - IN VITROANTIFERTILITY	ESTROGENIC EFFECT	Polygonum cuspidatum (POLYGONACEAE)	EMODIN
635825	PHARMACOLOGY OF EXTRACT - IN VITRO	UV ABSORBENT EFFECT	Polygonum cuspidatum (POLYGONACEAE)
1292041	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTEDHPLC SEPARATION DATA FOR		Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL,TRANS: BETA-D-GLUCOSIDERESVERATROL,CIS: BETA-D-GLUCOSIDERESVERATROL,CIS:RESVERATROL,TRANS:
758693	ISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	RESVERATROLPICEID
1274905	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATAQUANTITATIVE DATA REPORTEDHPLC SEPARATION DATA FOR		Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL,TRANS:
924760	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANS	HYPOCHOLESTEROLEMIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
1070792	PHARMACOLOGY OF EXTRACT - IN VITRO	SMOOTH MUSCLE RELAXANT ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
1098988	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIYEAST ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL
1194821	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIVIRAL ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
1087424	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANS	CHOLERETIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
295794	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	PICEID
856796	IDENTIFICATION OFPATENT DESCRIBED		Polygonum cuspidatum (POLYGONACEAE)	RESVERATROLBISADESTILBENE,2-3-4'-5-TETRAHYDROXY:
1148002	ISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL
1142813	PHARMACOLOGY OF COMPOUND - IN VIVO	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	PICEID
692061	PHARMACOLOGY OF EXTRACT - IN VITRO	MELANIN FORMATION INHIBITION	Polygonum cuspidatum (POLYGONACEAE)
1216303	VOUCHER SPECIMEN REPORTED FORMEDICINAL FOLKLORE REPORTED FOR	ANTIDIARRHEAL ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
496128	PHARMACOLOGY OF EXTRACT - IN VITRO	PROTEIN TYROSINE KINASE INHIBITION	Polygonum cuspidatum (POLYGONACEAE)
262120	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL,TRANS: 3-O-BETA-D-GLUCOPYRANOSIDE-6''-SULFATE
697011	PMR SPECTRUM REPORTEDWORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED		Polygonum cuspidatum (POLYGONACEAE)	PICEID,TRANS:RESVERATROL,TRANS:
1114847	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	CHROMONE,7-HYDROXY-2-5-DIMETHYL:
848009	ISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL
1098985	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIFUNGAL ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL
1120015	PHYTOCHEMICAL SCREENING FORVOUCHER SPECIMEN REPORTED FOR		Polygonum cuspidatum (POLYGONACEAE)	O
685787	ISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	RESVERATROLBENZOFURANONE,1(3H): ISO: 5-7-DIHYDROXY:PICEIDCHROMONE,5-CARBOXY-METHYL-7-HYDROXY-2-METHYL:COUMARIN,7-HYDROXY-4-METHOXY-5-METHYL:
295783	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)	LYONIRESINOL-2(A)-SULFATE,SODIUM: (-):LARICIRESINOL-2(A)-SULFATE,ISO: SODIUM: (+):ETHANE-1-2-DIOL,1-(3-5-DIHYDROXY-PHENYL)-2-(4''-HYDROXY-PHENYL):BENZOIC ACID METHYL ESTER-4-SULFATE,3-4-DIHYDROXY-5-METHOXY: SODIUM:
876123	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)	PICEID
262131	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL,CIS: 3-O-BETA-D-GLUCOPYRANOSIDE-6''-SULFATE
973963	PHARMACOLOGY OF COMPOUND - IN VITRO	TYROSINE KINASE INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	EMODIN-8-O-BETA-D-GLUCOSIDE
729241	PHARMACOLOGY OF EXTRACT - IN VITRO	PROTEIN KINASE C INHIBITION	Polygonum cuspidatum (POLYGONACEAE)
1114842	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	CITREOROSEIN
584253	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIVIRAL ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
1098990	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIYEAST ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL
711495	PHARMACOLOGY OF COMPOUND - IN VITRO	DNA SYNTHESIS INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL,TRANS:
529900	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIVIRAL ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
262121	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL,CIS: 3-O-BETA-D-GLUCOPYRANOSIDE-4''-SULFATERESVERATROL,CIS: 3-O-BETA-D-GLUCOPYRANOSIDE-5-SULFATERESVERATROL,CIS: 3-O-BETA-D-GLUCOPYRANOSIDE-6''-SULFATERESVERATROL,TRANS: 3-O-BETA-D-GLUCOPYRANOSIDE-2''-SULFATERESVERATROL,TRANS: 3-O-BETA-D-GLUCOPYRANOSIDE-5-SULFATERESVERATROL,CIS: 3-O-BETA-D-GLUCOPYRANOSIDE-2''-SULFATERESVERATROL,TRANS: 3-O-BETA-D-GLUCOPYRANOSIDE-4'-SULFATERESVERATROL,CIS: 3-O-BETA-D-GLUCOPYRANOSIDE-3''-SULFATERESVERATROL,TRANS: 3-O-BETA-D-GLUCOPYRANOSIDE-6''-SULFATE
280452	PHARMACOLOGY OF COMPOUND - IN VITRO	PROTEIN TYROSINE PHOSPHATASE INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	POLYGONUM DIMERIC STILBENE GLYCOSIDE 2
280437	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Polygonum cuspidatum (POLYGONACEAE)	POLYGONUM DIMERIC STILBENE GLYCOSIDE 1
1148006	PHARMACOLOGY OF COMPOUND - IN VIVO	CHOLESTEROL INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL
597743	PHARMACOLOGY OF EXTRACT - IN VITRO	REVERSE TRANSCRIPTASE INHIBITION	Polygonum cuspidatum (POLYGONACEAE)
1098989	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIYEAST ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL
876102	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	CHRYSOPHANIC ACID
741402	PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDWORK DESCRIBED MAINLY CONCERNS METHODOLOGYHPLC SEPARATION DATA FORISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	RESVERATROLPICEID
1114843	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	QUESTIN
973962	ISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	EMODIN-8-O-BETA-D-GLUCOSIDE
578153	PHARMACOLOGY OF EXTRACT - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIVIRAL ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
280447	PHARMACOLOGY OF COMPOUND - IN VITRO	LIPID PEROXIDE FORMATION INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	POLYGONUM DIMERIC STILBENE GLYCOSIDE 2
492686	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)	PICEID
1142812	PHARMACOLOGY OF COMPOUND - IN VIVO	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	PICEID
716840	PHARMACOLOGY OF COMPOUND - IN VITROANTIFERTILITY	ESTROGENIC EFFECT	Polygonum cuspidatum (POLYGONACEAE)	EMODIN-8-O-BETA-D-GLUCOSIDE
876113	PHARMACOLOGY OF COMPOUND - IN VITRO	RNA SYNTHESIS INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	EMODIN-8-O-BETA-D-GLUCOSIDE
502160	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
1089474	PHARMACOLOGY OF EXTRACT - IN VIVOVOUCHER SPECIMEN REPORTED FORANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTITUMOR ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
1190699	MEDICINAL FOLKLORE REPORTED FOR	ANTIBURN EFFECT	Polygonum cuspidatum (POLYGONACEAE)
1242949	PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED	HYPOGLYCEMIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
854210	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTITHROMBOTIC EFFECT	Polygonum cuspidatum (POLYGONACEAE)
497226	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIVIRAL ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
716841	PHARMACOLOGY OF COMPOUND - IN VITRO	ESTROGEN RECEPTOR(ALPHA) BINDING EFFECT	Polygonum cuspidatum (POLYGONACEAE)	EMODIN-8-O-BETA-D-GLUCOSIDE
496130	PHARMACOLOGY OF COMPOUND - IN VITRO	PROTEIN TYROSINE KINASE INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL
730691	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL
262128	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL,TRANS: 3-O-BETA-D-GLUCOPYRANOSIDE-2''-SULFATE
280441	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)	POLYGONUM DIMERIC STILBENE GLYCOSIDE 1
492675	ISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL
711488	PHARMACOLOGY OF COMPOUND - IN VIVO	METASTASIS INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL,TRANS:
262125	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIYEAST ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL,CIS: 3-O-BETA-D-GLUCOPYRANOSIDE-4''-SULFATERESVERATROL,TRANS: 3-O-BETA-D-GLUCOPYRANOSIDE-4''-SULFATERESVERATROL,CIS: 3-O-BETA-D-GLUCOPYRANOSIDE-5-SULFATERESVERATROL,CIS: 3-O-BETA-D-GLUCOPYRANOSIDE-6''-SULFATERESVERATROL,TRANS: 3-O-BETA-D-GLUCOPYRANOSIDE-2''-SULFATERESVERATROL,TRANS: 3-O-BETA-D-GLUCOPYRANOSIDE-5-SULFATERESVERATROL,CIS: 3-O-BETA-D-GLUCOPYRANOSIDE-2''-SULFATERESVERATROL,TRANS: 3-O-BETA-D-GLUCOPYRANOSIDE-4'-SULFATERESVERATROL,CIS: 3-O-BETA-D-GLUCOPYRANOSIDE-3''-SULFATERESVERATROL,TRANS: 3-O-BETA-D-GLUCOPYRANOSIDE-6''-SULFATE
650483	MEDICINAL FOLKLORE REPORTED FOR	FOOD USE	Polygonum cuspidatum (POLYGONACEAE)
635823	PHARMACOLOGY OF EXTRACT - IN VITRO	TYROSINASE INHIBITION	Polygonum cuspidatum (POLYGONACEAE)
300789	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Polygonum cuspidatum (POLYGONACEAE)	CHROMONE,5-CARBOXY-METHYL-7-HYDROXY-2-METHYL:
1303469	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	RESVERATROLPICEIDEMODINPHYSCIONCITREOROSEIN
1153816	ISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL
876124	PHARMACOLOGY OF COMPOUND - IN VITRO	DNA SYNTHESIS INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	PICEID
706393	VOUCHER SPECIMEN REPORTED FORQUANTITATIVE DATA REPORTEDISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL,CIS:
295786	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Polygonum cuspidatum (POLYGONACEAE)	BENZOIC ACID METHYL ESTER-4-SULFATE,3-4-DIHYDROXY-5-METHOXY: SODIUM:
1075729	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTITOXIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
492682	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)	PICEID
492679	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL
1065403	PHARMACOLOGY OF EXTRACT - IN VIVO	WOUND HEALING ACCELERATION	Polygonum cuspidatum (POLYGONACEAE)	TANNIN(CONDENSED)
729242	PHARMACOLOGY OF EXTRACT - IN VITRO	PROTEIN KINASE C INHIBITION	Polygonum cuspidatum (POLYGONACEAE)
703282	PHARMACOLOGY OF EXTRACT - IN VITRO	PROTEASE(HIV) INHIBITION	Polygonum cuspidatum (POLYGONACEAE)
492680	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL
457464	PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGS	ANTIVENIN EFFECT	Polygonum cuspidatum (POLYGONACEAE)
1244101	PRESENT IN (REVIEW)CRUDE DRUG DESCRIPTIONMICROSCOPY OF		Polygonum cuspidatum (POLYGONACEAE)	ALOE EMODINFRANGULA EMODINPOLYGONIN
552749	PHARMACOLOGY OF COMPOUND - IN VITRO	GENOTOXICITY INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	EMODIN
706399	ISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	PICEID,CIS:
924764	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANS	HYPOTRIGLYCERIDEMIA ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
848022	PHARMACOLOGY OF COMPOUND - IN VITRO	PLATELET AGGREGATION INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	PICEID
1114841	ANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)MEDICINAL FOLKLORE REPORTED FOR	ANTIFUNGAL ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
440364	PHARMACOLOGY OF EXTRACT - IN VITRO	HEPATITIS ANTIGEN EXPRESSION INHIBITION	Polygonum cuspidatum (POLYGONACEAE)
262133	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL,CIS: 3-O-BETA-D-GLUCOPYRANOSIDE-3''-SULFATE
1142817	ANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)MEDICINAL FOLKLORE REPORTED FOR	ANTIBACTERIAL ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
969061	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIMUTAGENIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
876115	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)	PHYSCION
1098992	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL
876104	PHARMACOLOGY OF COMPOUND - IN VITRO	DNA SYNTHESIS INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	CHRYSOPHANIC ACID
711489	PHARMACOLOGY OF COMPOUND - IN VITRO	DNA SYNTHESIS INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL,TRANS:
1148008	PHARMACOLOGY OF COMPOUND - IN VIVO	LIPID METABOLISM EFFECTS	Polygonum cuspidatum (POLYGONACEAE)	PICEID
1098981	ANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)MEDICINAL FOLKLORE REPORTED FOR	ANTIBACTERIAL ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
535	PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY	GONADOTROPIN SYNTHESIS STIMULATION(UNSPECIFIED)	Polygonum cuspidatum (POLYGONACEAE)
792740	PHYTOCHEMICAL SCREENING FOR		Polygonum cuspidatum (POLYGONACEAE)	O
1278271	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATAHPLC SEPARATION DATA FOR		Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL,CIS: BETA-D-GLUCOSIDE
1065400	QUANTITATIVE DATAIDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	TANNIN(CONDENSED)
848016	ISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	PICEID
856797	IDENTIFICATION OFPATENT DESCRIBED		Polygonum cuspidatum (POLYGONACEAE)
1245119	IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)
295780	PHARMACOLOGY OF COMPOUND - IN VITRO	LIPID PEROXIDE FORMATION INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	LYONIRESINOL-2(A)-SULFATE,SODIUM: (-):LARICIRESINOL-2(A)-SULFATE,ISO: SODIUM: (+):ETHANE-1-2-DIOL,1-(3-5-DIHYDROXY-PHENYL)-2-(4''-HYDROXY-PHENYL):BENZOIC ACID METHYL ESTER-4-SULFATE,3-4-DIHYDROXY-5-METHOXY: SODIUM:
295779	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FOR		Polygonum cuspidatum (POLYGONACEAE)	LYONIRESINOL-2(A)-SULFATE,SODIUM: (-):
262122	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL,CIS: 3-O-BETA-D-GLUCOPYRANOSIDE-4''-SULFATERESVERATROL,TRANS: 3-O-BETA-D-GLUCOPYRANOSIDE-4''-SULFATERESVERATROL,CIS: 3-O-BETA-D-GLUCOPYRANOSIDE-5-SULFATERESVERATROL,CIS: 3-O-BETA-D-GLUCOPYRANOSIDE-6''-SULFATERESVERATROL,TRANS: 3-O-BETA-D-GLUCOPYRANOSIDE-2''-SULFATERESVERATROL,TRANS: 3-O-BETA-D-GLUCOPYRANOSIDE-5-SULFATERESVERATROL,CIS: 3-O-BETA-D-GLUCOPYRANOSIDE-2''-SULFATERESVERATROL,TRANS: 3-O-BETA-D-GLUCOPYRANOSIDE-4'-SULFATERESVERATROL,CIS: 3-O-BETA-D-GLUCOPYRANOSIDE-3''-SULFATERESVERATROL,TRANS: 3-O-BETA-D-GLUCOPYRANOSIDE-6''-SULFATE
1324913	ISOLATION OF COMPOUND WITH UNKNOWN STRUCTURE		Polygonum cuspidatum (POLYGONACEAE)	POLYSACCHARIDE(POLYGONUM CUSPIDATUM)
561455	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIMUTAGENIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
262130	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL,TRANS: 3-O-BETA-D-GLUCOPYRANOSIDE-5-SULFATE
1198627	PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FOR	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	Polygonum cuspidatum (POLYGONACEAE)
751361	ISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	DECURSIN
876122	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	PICEID
729240	VOUCHER SPECIMEN REPORTED FOR		Polygonum cuspidatum (POLYGONACEAE)
1216304	VOUCHER SPECIMEN REPORTED FORANTIFERTILITYMEDICINAL FOLKLORE REPORTED FOR	MENSTRUATION INDUCTION EFFECT	Polygonum cuspidatum (POLYGONACEAE)
973960	ISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	PHYSCION
496129	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL
716837	PHARMACOLOGY OF COMPOUND - IN VITRO	ESTROGEN RECEPTOR(ALPHA) BINDING EFFECT	Polygonum cuspidatum (POLYGONACEAE)	EMODIN
280448	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)	POLYGONUM DIMERIC STILBENE GLYCOSIDE 2
1261285	ISOLATION AND IDENTIFICATION AFTER CHEMICAL TREATMENT		Polygonum cuspidatum (POLYGONACEAE)	EMODIN
280451	PHARMACOLOGY OF COMPOUND - IN VITRO	DNA DISRUPTION EFFECT	Polygonum cuspidatum (POLYGONACEAE)	POLYGONUM DIMERIC STILBENE GLYCOSIDE 2
492683	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)	PICEID
534703	PHARMACOLOGY OF EXTRACT - IN VITRO	RADICAL SCAVENGING EFFECT	Polygonum cuspidatum (POLYGONACEAE)
1148004	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTIHYPERCHOLESTEROLEMIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL
770968	VOUCHER SPECIMEN REPORTED FOR		Polygonum cuspidatum (POLYGONACEAE)
280443	PHARMACOLOGY OF COMPOUND - IN VITRO	DNA DISRUPTION EFFECT	Polygonum cuspidatum (POLYGONACEAE)	POLYGONUM DIMERIC STILBENE GLYCOSIDE 1
635824	PHARMACOLOGY OF EXTRACT - IN VITRO	TYROSINASE INHIBITION	Polygonum cuspidatum (POLYGONACEAE)
758694	PHARMACOLOGY OF COMPOUND - IN VITRO	DNA SYNTHESIS INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	RESVERATROLPICEID
1202432	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIVIRAL ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
1070793	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	Polygonum cuspidatum (POLYGONACEAE)
29204	ISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	QUERCITRINQUERCITRIN,ISO:RUTIN
280444	PHARMACOLOGY OF COMPOUND - IN VITRO	PROTEIN TYROSINE PHOSPHATASE INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	POLYGONUM DIMERIC STILBENE GLYCOSIDE 1
295787	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	GALLIC ACID
262134	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL,CIS: 3-O-BETA-D-GLUCOPYRANOSIDE-2''-SULFATE
262126	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL,TRANS: 3-O-BETA-D-GLUCOPYRANOSIDE-4''-SULFATE
496134	PHARMACOLOGY OF COMPOUND - IN VITRO	PROTEIN TYROSINE KINASE INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL-4'-O-BETA-D-GLUCOSIDE
561459	PHARMACOLOGY OF COMPOUND - IN VITRO	LARVAL GROWTH INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	EMODIN
850961	PRESENT IN (REVIEW)CHEMOTAXONOMY MARKER CODE		Polygonum cuspidatum (POLYGONACEAE)	RESVERATROLPICEIDEMODIN-8-O-BETA-D-GLUCOSIDEPHYSCIONEMODINDAUCOSTEROL
1244959	ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Polygonum cuspidatum (POLYGONACEAE)	POLYDATOSIDE
1114848	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	COUMARIN,7-HYDROXY-4-METHOXY-5-METHYL:
1148011	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTIHYPERLIPEMIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)	PICEID
770969	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIVIRAL ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
711492	PHARMACOLOGY OF COMPOUND - IN VIVO	CALCIUM CHANNEL BLOCKER	Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL,TRANS:
1243455	ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Polygonum cuspidatum (POLYGONACEAE)	POLYDATOSIDE
848015	PHARMACOLOGY OF COMPOUND - IN VITRO	PLATELET AGGREGATION INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL
1214414	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIVIRAL ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
1304514	REVIEW OF		Polygonum cuspidatum (POLYGONACEAE)
699011	PRESENT IN (REVIEW)REVIEW OF		Polygonum cuspidatum (POLYGONACEAE)	PICEID
1070464	PHARMACOLOGY OF EXTRACT - IN VIVOVOUCHER SPECIMEN REPORTED FOR	BARBITURATE SLEEPING TIME DECREASED	Polygonum cuspidatum (POLYGONACEAE)
771523	PHARMACOLOGY OF EXTRACT - IN VITRO	LIPID PEROXIDE FORMATION INHIBITION	Polygonum cuspidatum (POLYGONACEAE)
712272	PHARMACOLOGY OF EXTRACT - IN VITRO	FREE RADICAL FORMATION INHIBITION	Polygonum cuspidatum (POLYGONACEAE)
973959	PHARMACOLOGY OF COMPOUND - IN VITRO	TYROSINE KINASE INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	EMODIN
492678	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL
760442	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIVIRAL ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
876112	PHARMACOLOGY OF COMPOUND - IN VITRO	DNA SYNTHESIS INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	EMODIN-8-O-BETA-D-GLUCOSIDE
1142820	MEDICINAL FOLKLORE REPORTED FOR	HYPOCHOLESTEROLEMIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
280440	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)	POLYGONUM DIMERIC STILBENE GLYCOSIDE 1
1114844	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	QUESTINOL
706395	PHARMACOLOGY OF COMPOUND - IN VITRO	RNA SYNTHESIS INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL,CIS:
1198626	PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FOR	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	Polygonum cuspidatum (POLYGONACEAE)
711494	PHARMACOLOGY OF COMPOUND - IN VITRO	DNA SYNTHESIS INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL,TRANS:
550646	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIMUTAGENIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
1244324	IDENTIFICATION OF		Polygonum cuspidatum (POLYGONACEAE)	EMODIN
848012	PHARMACOLOGY OF COMPOUND - IN VITRO	CYCLOOXYGENASE INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL
706394	PHARMACOLOGY OF COMPOUND - IN VITRO	DNA SYNTHESIS INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL,CIS:
716833	PHARMACOLOGY OF EXTRACT - IN VITROANTIFERTILITY	ESTROGENIC EFFECT	Polygonum cuspidatum (POLYGONACEAE)
15169	PHARMACOLOGY OF EXTRACT - IN VIVOVOUCHER SPECIMEN REPORTED FOR	CNS DEPRESSANT ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
1148005	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTIHYPERLIPEMIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL
729243	PHARMACOLOGY OF EXTRACT - IN VITRO	PROTEIN KINASE C INHIBITION	Polygonum cuspidatum (POLYGONACEAE)
1089473	PHARMACOLOGY OF EXTRACT - IN VIVOVOUCHER SPECIMEN REPORTED FORANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTITUMOR ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
848017	PHARMACOLOGY OF COMPOUND - IN VITRO	LIPOXYGENASE INHIBITION	Polygonum cuspidatum (POLYGONACEAE)	PICEID
957293	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIOXIDANT ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
924763	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANS	HYPOCHOLESTEROLEMIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)
492676	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Polygonum cuspidatum (POLYGONACEAE)	RESVERATROL

Experiments for taxon Polygonum cuspidatum (POLYGONACEAE)

Experiments (398 results)

Filters

Worktypes (37)

Pharmacology (86)

Compounds (89)

Organisms (122)